PL2383289T3 - Antagoniści somatostatyny selektywni względem receptora (SSTR2) - Google Patents

Antagoniści somatostatyny selektywni względem receptora (SSTR2)

Info

Publication number: PL2383289T3
Authority: PL; Poland
Prior art keywords: sstr2; receptor; somatostatin antagonists; selective somatostatin; selective
Prior art date: 2006-10-16

Application number

PL11173287T

Other languages

English (en)

Inventor

Jean E F Rivier

Judit Erchegyi

Jean Claude Reubi

Helmut R Maecke

Original Assignee

Salk Inst Biological Studies

Univ Bern Verwaltungsdirektion

Univ Hospital Basel

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-16

Filing date

2007-10-15

Publication date

2015-03-31

2007-10-15 Application filed by Salk Inst Biological Studies, Univ Bern Verwaltungsdirektion, Univ Hospital Basel filed Critical Salk Inst Biological Studies

2015-03-31 Publication of PL2383289T3 publication Critical patent/PL2383289T3/pl

Links

101000829127 Homo sapiens Somatostatin receptor type 2 Proteins 0.000 title 1
102000005157 Somatostatin Human genes 0.000 title 1
108010056088 Somatostatin Proteins 0.000 title 1
102100023802 Somatostatin receptor type 2 Human genes 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
102000005962 receptors Human genes 0.000 title 1
108020003175 receptors Proteins 0.000 title 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
229960000553 somatostatin Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

PL11173287T 2006-10-16 2007-10-15 Antagoniści somatostatyny selektywni względem receptora (SSTR2) PL2383289T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US82963706P	2006-10-16	2006-10-16
EP11173287.1A EP2383289B1 (en)	2006-10-16	2007-10-15	Receptor (SSTR2)-selective somatostatin antagonists
EP07854075A EP2076535B1 (en)	2006-10-16	2007-10-15	Receptor(sstr2)-selective somatostatin antagonists

Publications (1)

Publication Number	Publication Date
PL2383289T3 true PL2383289T3 (pl)	2015-03-31

Family

ID=39144622

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PL11173287T PL2383289T3 (pl)	2006-10-16	2007-10-15	Antagoniści somatostatyny selektywni względem receptora (SSTR2)
PL11194516T PL2433963T3 (pl)	2006-10-16	2007-10-15	Antagoniści somatostatyny selektywni względem receptora (SSTR2)
PL07854075T PL2076535T3 (pl)	2006-10-16	2007-10-15	Antagoniści somatostatyny selektywni względem receptora (SSTR2)

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
PL11194516T PL2433963T3 (pl)	2006-10-16	2007-10-15	Antagoniści somatostatyny selektywni względem receptora (SSTR2)
PL07854075T PL2076535T3 (pl)	2006-10-16	2007-10-15	Antagoniści somatostatyny selektywni względem receptora (SSTR2)

Country Status (13)

Country	Link
US (2)	US7960342B2 (pl)
EP (3)	EP2433963B1 (pl)
JP (1)	JP5295967B2 (pl)
CN (2)	CN101631801B (pl)
AU (1)	AU2007311137B2 (pl)
BR (1)	BRPI0717135B8 (pl)
CA (1)	CA2666642C (pl)
DK (1)	DK2076535T3 (pl)
ES (2)	ES2526292T3 (pl)
PL (3)	PL2383289T3 (pl)
PT (1)	PT2076535E (pl)
SI (1)	SI2076535T1 (pl)
WO (1)	WO2008048942A2 (pl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8691761B2 (en) *	2006-10-16	2014-04-08	Jean E. F. Rivier	Somatostatin receptor 2 antagonists
PL2383289T3 (pl)	2006-10-16	2015-03-31	Salk Inst Biological Studies	Antagoniści somatostatyny selektywni względem receptora (SSTR2)
PL2118123T3 (pl)	2007-01-31	2016-06-30	Dana Farber Cancer Inst Inc	Stabilizowane peptydy p53 i ich zastosowania
JP5631201B2 (ja)	2007-03-28	2014-11-26	プレジデントアンドフェローズオブハーバードカレッジ	ステッチングされたポリペプチド
KR102104762B1 (ko)	2010-08-13	2020-04-24	에일러론 테라퓨틱스 인코포레이티드	펩티도미메틱 거대고리
US12466897B2 (en)	2011-10-10	2025-11-11	Xencor, Inc.	Heterodimeric human IgG1 polypeptides with isoelectric point modifications
EP2768518A4 (en)	2011-10-18	2015-05-27	Aileron Therapeutics Inc	PEPTIDOMIMETIC MACROCYCLES
RU2642299C2 (ru)	2012-02-15	2018-01-24	Эйлерон Терапьютикс, Инк.	P53 пептидомиметические макроциклы
CA2864120A1 (en)	2012-02-15	2013-08-22	Aileron Therapeutics, Inc.	Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
BR112015009470A2 (pt)	2012-11-01	2019-12-17	Aileron Therapeutics Inc	aminoácidos dissubstituídos e seus métodos de preparação e uso
US11053316B2 (en)	2013-01-14	2021-07-06	Xencor, Inc.	Optimized antibody variable regions
CA2898100C (en)	2013-01-14	2023-10-10	Xencor, Inc.	Novel heterodimeric proteins
US10858417B2 (en)	2013-03-15	2020-12-08	Xencor, Inc.	Heterodimeric proteins
JP6775422B2 (ja)	2014-03-28	2020-10-28	ゼンコー・インコーポレイテッドＸｅｎｃｏｒ、Ｉｎｃ．	Ｃｄ３８及びｃｄ３に結合する二重特異性抗体
CN104045690B (zh) *	2014-06-25	2016-06-08	舟山医院	生长抑素受体激动剂多肽及其应用
CN104086630B (zh) *	2014-06-25	2016-06-29	天津欧德莱生物医药科技有限公司	一种生长抑素受体激动剂多肽及其应用
CN104045689B (zh) *	2014-06-25	2016-08-24	新乡医学院	一种关于生长抑素受体激动剂多肽及其应用
EP3197478A4 (en)	2014-09-24	2018-05-30	Aileron Therapeutics, Inc.	Peptidomimetic macrocycles and uses thereof
CN104491890A (zh) *	2014-11-21	2015-04-08	北京肿瘤医院	放射性核素标记的新型生长抑素类似物分子探针及其应用
SG11201704283PA (en)	2014-11-26	2017-06-29	Xencor Inc	Heterodimeric antibodies that bind cd3 and tumor antigens
US10259887B2 (en)	2014-11-26	2019-04-16	Xencor, Inc.	Heterodimeric antibodies that bind CD3 and tumor antigens
JP2017536830A (ja)	2014-11-26	2017-12-14	ゼンコー・インコーポレイテッドＸｅｎｃｏｒ、Ｉｎｃ．	Ｃｄ３及びｃｄ３８に結合するヘテロ二量体抗体
JP2018516844A (ja)	2015-03-20	2018-06-28	エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	ペプチド模倣大環状分子およびその使用
JP7058219B2 (ja)	2015-12-07	2022-04-21	ゼンコアインコーポレイテッド	Ｃｄ３及びｐｓｍａに結合するヘテロ二量体抗体
US11279732B2 (en)	2016-02-09	2022-03-22	Cdrd Ventures Inc.	Somatostatin receptor antagonist compounds and methods of using the same
MA45255A (fr)	2016-06-14	2019-04-17	Xencor Inc	Anticorps inhibiteurs de points de contrôle bispécifiques
KR20190020341A (ko)	2016-06-28	2019-02-28	젠코어 인코포레이티드	소마토스타틴 수용체 2에 결합하는 이종이량체 항체
US10849955B2 (en)	2016-09-28	2020-12-01	City Of Hope	Methods of treating pancreatic cancer using GPCR antagonists
AU2018366199A1 (en)	2017-11-08	2020-05-28	Xencor, Inc.	Bispecific and monospecific antibodies using novel anti-PD-1 sequences
AU2019247415A1 (en)	2018-04-04	2020-10-22	Xencor, Inc.	Heterodimeric antibodies that bind fibroblast activation protein
TW202015744A (zh)	2018-06-21	2020-05-01	法商艾普森藥品公司	用於放射性醫藥之含有體抑素類似物之組成物
TW202547563A (zh) *	2018-06-21	2025-12-16	德商愛利穆治療有限公司	用於放射性醫藥之含有體抑素類似物之組成物
WO2021231976A1 (en)	2020-05-14	2021-11-18	Xencor, Inc.	Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3
CA3192204A1 (en)	2020-08-19	2022-02-24	Xencor, Inc.	Anti-cd28 and/or anti-b7h3 compositions
KR20230156079A (ko)	2021-03-09	2023-11-13	젠코어 인코포레이티드	Cd3과 cldn6에 결합하는 이종이량체 항체
US11859012B2 (en)	2021-03-10	2024-01-02	Xencor, Inc.	Heterodimeric antibodies that bind CD3 and GPC3
DE102021111452B3 (de) *	2021-05-04	2022-07-28	Positron Precision GmbH	Markierungsvorläufer und Radiotracer für neuroendokrine Theranostik
CN116284225A (zh) *	2021-12-20	2023-06-23	南京江原安迪科正电子研究发展有限公司	一种新型生长抑素类似物及其分子探针、制备方法与应用
WO2024064969A2 (en)	2022-09-23	2024-03-28	Nuclidium Ag	High-purity copper radiopharmaceutical compositions and diagnostic and therapeutic uses thereof
TW202426433A (zh)	2022-09-23	2024-07-01	瑞士商紐利迪姆股份公司	成纖維細胞活化蛋白（ｆａｐ）抑制劑、ｆａｐ結合物及其診斷與治療用途
CN115583989B (zh) *	2022-12-09	2023-02-28	烟台蓝纳成生物技术有限公司	一种靶向sstr2的化合物及其制备方法和应用
CN119708199A (zh) *	2023-09-27	2025-03-28	钱杭江医药科技(嘉兴)有限公司	生长抑素肽类类似物、螯合物及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3773919A (en) *	1969-10-23	1973-11-20	Du Pont	Polylactide-drug mixtures
US3904594A (en) *	1973-07-02	1975-09-09	Salk Inst For Biological Studi	Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US4372884A (en)	1975-08-06	1983-02-08	The Salk Institute For Biological Studies	Pharmaceutically active peptides
US4428942A (en)	1982-05-17	1984-01-31	The Salk Institute For Biological Studies	Analogs of somatostatin
US4725577A (en) *	1985-04-25	1988-02-16	Administrators Of The Tulane Educational Fund	Biologically active lysine containing octapeptides
US5776894A (en) *	1988-12-05	1998-07-07	Novartis Ag	Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US7238340B1 (en) *	1991-11-27	2007-07-03	Cis Bio International	Monoamine, diamide, thiol-containing metal chelating agents
US5590656A (en)	1992-09-15	1997-01-07	The Ohio State University Research Foundation	Application of peptide/cell receptor kinetics utilizing radiolabeled somatostatin congeners in the in situ, in vivo detection and differentiation of neoplastic tissue
US5879657A (en)	1993-03-30	1999-03-09	The Dupont Merck Pharmaceutical Company	Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
CA2183421A1 (en)	1994-02-18	1995-08-24	John Mertens	Labelled peptide compounds
US5663292A (en)	1994-12-12	1997-09-02	The Salk Institute For Biological Studies	Cyclic CRF analogs
US5688489A (en) *	1995-09-15	1997-11-18	Resolution Pharmaceuticals, Inc.	Non-receptor mediated imaging agents
US5708135A (en)	1995-09-29	1998-01-13	Biomeasure Incorporated	Cyclic peptide analogs of somatostatin
US5750499A (en)	1995-10-18	1998-05-12	The Salk Institute For Biological Studies	Receptor-selective somatostatin analogs
US5846934A (en)	1996-02-20	1998-12-08	American Cyanamid Company	Pure somatostatin antagonist and methods of use thereof
IL130166A0 (en) *	1996-12-04	2000-06-01	Sod Conseils Rech Applic	Somatostatin antagonists
US6262229B1 (en)	1996-12-04	2001-07-17	Biomeasure Incorporated	Somatostatin antagonists
US5925618A (en)	1997-03-06	1999-07-20	American Cyanamid Company	Peptides useful as somatostatin antagonists
CA2246791A1 (en)	1998-09-01	2000-03-01	Alison Buchan	Treatment of endothelium with somatostatin analogues
US6579967B1 (en)	1999-12-14	2003-06-17	The Salk Institute For Biological Studies	Receptor-selective somatostatin analogs
AU3290302A (en)	2000-10-20	2002-04-29	Univ Tulane	Urotensin-ii agonists and antagonists
RU2263678C2 (ru) *	2001-03-08	2005-11-10	Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд	Антагонисты соматостатина
US7019109B2 (en)	2001-03-16	2006-03-28	The Salk Institute For Bilogical Studies	SSTR1-selective analogs
EP1283216A1 (en)	2001-08-10	2003-02-12	Mallinckrodt Inc.	Somatostatin analogues binding to all somatostatin receptor subtypes and their use
PL369336A1 (pl)	2001-09-21	2005-04-18	The Administrators Of The Tulane Educational Fund	Diagnostyczne lub terapeutyczne koniugaty analogów somatostatyny lub bombezyny i ich zastosowania
WO2004009614A2 (en)	2002-07-24	2004-01-29	The Salk Institute For Biological Studies	Receptor (sstr4)- selective somatostatin analogs
DK1603598T3 (da)	2003-03-19	2009-01-26	Univ Bern	Radiomærkede konjugater baseret på substans P og anvendelser heraf
PL2383289T3 (pl)	2006-10-16	2015-03-31	Salk Inst Biological Studies	Antagoniści somatostatyny selektywni względem receptora (SSTR2)

2007
- 2007-10-15 PL PL11173287T patent/PL2383289T3/pl unknown
- 2007-10-15 BR BRPI0717135A patent/BRPI0717135B8/pt active IP Right Grant
- 2007-10-15 EP EP11194516.8A patent/EP2433963B1/en active Active
- 2007-10-15 SI SI200731231T patent/SI2076535T1/sl unknown
- 2007-10-15 WO PCT/US2007/081430 patent/WO2008048942A2/en not_active Ceased
- 2007-10-15 CN CN2007800386522A patent/CN101631801B/zh active Active
- 2007-10-15 CN CN201310138908.4A patent/CN103288919B/zh active Active
- 2007-10-15 US US11/872,367 patent/US7960342B2/en active Active
- 2007-10-15 PL PL11194516T patent/PL2433963T3/pl unknown
- 2007-10-15 AU AU2007311137A patent/AU2007311137B2/en active Active
- 2007-10-15 EP EP07854075A patent/EP2076535B1/en active Active
- 2007-10-15 ES ES11173287.1T patent/ES2526292T3/es active Active
- 2007-10-15 ES ES07854075T patent/ES2410207T3/es active Active
- 2007-10-15 JP JP2009533471A patent/JP5295967B2/ja active Active
- 2007-10-15 PT PT78540754T patent/PT2076535E/pt unknown
- 2007-10-15 EP EP11173287.1A patent/EP2383289B1/en active Active
- 2007-10-15 CA CA2666642A patent/CA2666642C/en active Active
- 2007-10-15 DK DK07854075.4T patent/DK2076535T3/da active
- 2007-10-15 PL PL07854075T patent/PL2076535T3/pl unknown
2011
- 2011-06-13 US US13/159,020 patent/US8501687B2/en active Active

Also Published As

Publication number	Publication date
BRPI0717135B8 (pt)	2021-05-25
EP2076535B1 (en)	2013-03-06
PT2076535E (pt)	2013-06-12
CN103288919B (zh)	2014-11-12
US7960342B2 (en)	2011-06-14
JP5295967B2 (ja)	2013-09-18
ES2526292T3 (es)	2015-01-09
US20110269683A1 (en)	2011-11-03
CN101631801A (zh)	2010-01-20
JP2010506943A (ja)	2010-03-04
ES2410207T3 (es)	2013-07-01
DK2076535T3 (da)	2013-06-10
AU2007311137B2 (en)	2013-06-20
SI2076535T1 (sl)	2013-07-31
US20080260638A1 (en)	2008-10-23
BRPI0717135B1 (pt)	2020-09-15
US8501687B2 (en)	2013-08-06
CN103288919A (zh)	2013-09-11
WO2008048942A3 (en)	2008-09-18
AU2007311137A1 (en)	2008-04-24
EP2433963A1 (en)	2012-03-28
WO2008048942A2 (en)	2008-04-24
EP2383289B1 (en)	2014-10-08
BRPI0717135A2 (pt)	2013-10-15
PL2076535T3 (pl)	2013-08-30
CA2666642C (en)	2015-11-17
EP2433963B1 (en)	2014-06-04
CA2666642A1 (en)	2008-04-24
HK1132515A1 (en)	2010-02-26
EP2076535A2 (en)	2009-07-08
EP2383289A1 (en)	2011-11-02
CN101631801B (zh)	2013-06-05
PL2433963T3 (pl)	2014-11-28

Publication	Publication Date	Title
SI2076535T1 (sl)	2013-07-31	Antagonisti somatostatina, selektivni za receptor (SSTR2)
IL196056A0 (en)	2009-09-01	Il-8 receptor antagonists
PT1981902E (pt)	2015-11-02	Antagonistas dos recetores nogo
IL194811A0 (en)	2009-08-03	Il-8 receptor antagonists
EP2099454A4 (en)	2010-11-10	AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS
PT2129654E (pt)	2014-09-04	Antagonistas do receptor de glucagina
EP2058304A4 (en)	2012-10-10	P2X4 RECEPTOR ANTAGONIST
ZA200904150B (en)	2010-11-24	Progesterone receptor antagonists
IL182355A0 (en)	2007-07-24	Thrombin receptor antagonists
IL194700A0 (en)	2009-08-03	Il-8 receptor antagonists
EP2099300A4 (en)	2011-12-07	IL-8 RECEPTOR ANTAGONISTS
BRPI0910592A2 (pt)	2015-09-22	antagonistas de receptor 2 de somatostatina
IL195807A0 (en)	2009-09-01	Cgrp receptor antagonists
IL198542A0 (en)	2010-02-17	2-aminoquinolines as 5-ht(5a)receptor antagonists
IL199430A0 (en)	2010-03-28	Crth2 antagonists
TWI341198B (en)	2011-05-01	Hydroisoindoline tachykinin receptor antagonists
IL192693A0 (en)	2009-09-22	Urotensin ii receptor antagonists
EP1812008A4 (en)	2008-10-29	ANTAGONISTS OF THE IL-8 RECEPTOR
EP1874302A4 (en)	2009-12-16	ANTAGONISTS OF ANGIOTENSIN II RECEPTORS
ZA200904479B (en)	2010-09-29	Nitroderivatives as angiotensin II receptor antagonists
IL196758A0 (en)	2009-11-18	Urotensin ii receptor antagonists
ZA200903499B (en)	2010-03-31	Indoles which act as via receptor antagonists
ZA200605574B (en)	2007-12-27	Hydroisoindoline tachykinin receptor antagonists
HK1152719A (en)	2012-03-09	Somatostatin receptor 2 antagonists
HK1125309A (en)	2009-08-07	Il-8 receptor antagonists